AZ adds new heart warning to Seroquel
July 21, 2011Sales and Marketing Seroquel, antipsychotic
AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
Merck signs major deal with China’s Simcere
July 21, 2011Sales and Marketing Merck, Simcere, emerging markets
Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …
Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products
July 20, 2011Manufacturing and Production
Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …
NICE says no to breast cancer treatment Halaven
July 20, 2011Sales and Marketing Eisai, Halaven, NICE
Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …
Analysis paralysis – how to get the true measure of clinical trials
July 20, 2011Research and Development Les Rose, clinical trials
The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …
Future of AZ-BMS diabetes drug in doubt
July 20, 2011Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news
A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
Hep C drug Victrelis gains EU approval
July 20, 2011Sales and Marketing Incivek, Victrelis, hepatitis C
Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
Contract research news in brief
July 20, 2011Research and Development research and development news
M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
Government seeks to salvage pharma pricing reforms
July 19, 2011Sales and Marketing NICE, value-based pricing
The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
Hepatitis C rivals go head to head
July 19, 2011Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
Novartis posts double-digit sales and profit growth
July 19, 2011Sales and Marketing Novartis
Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …
In search of authenticity
July 19, 2011Sales and Marketing
We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …
Sweden seeks GMP revisions to tackle environmental pollution
July 19, 2011Manufacturing and Production pharma manufacturing news
Wholesale shifting of pharmaceutical production to low-cost countries such as India and China is creating environmental impacts “on a scale …
Lonza wins another antibody contract
July 19, 2011Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news
Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …
New joint venture plans to tap into global generics market
July 19, 2011Ajinomoto OmniChem, Granules India, pharma manufacturing news
Belgian fine chemicals company Ajinomoto OmniChem has forged a joint venture with Granules India to produce active pharmaceutical ingredients and …
ASCO 2011: news from the front line against cancer
July 18, 2011Research and Development ASCO, Cancer, oncology
Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
NICE decides laser treatment better than Lucentis
July 18, 2011Sales and Marketing Lucentis, NICE, Novartis
Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …
Amgen bone cancer drug Xgeva approved in Europe
July 18, 2011Sales and Marketing Amgen, Prolia, Xgeva, denosumab
Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …
GSK downsizes Irish OTC plant
July 18, 2011Manufacturing and Production GSK, Ireland, pharma manufacturing news
GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …
Pharma manufacturing news in brief
July 18, 2011Manufacturing and Production pharma manufacturing news
Our round-up of news in the pharmaceutical manufacturing sector includes facility updates from NanoSonic, Tianyin Pharma, Orchid and Boehringer Ingelheim, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
